|GemmaCert invites medical practitioners and scientists worldwide to collaborate with it in the much-needed effort to advance the study into the correlation between medical cannabis composition and efficacy.
A new initiative was announced in Canada to study the efficacy of medical cannabis for specific conditions and help physicians prescribe it at the right dose, for the right patient. This is very good news. Doctors seek scientific evidence rather than anecdotal testimonials. Patients want better quality of life; here and now.
Cannabis is a natural product with hundreds of active ingredients. No two flowers are the same. A patient even when using the same strain and the same amount of medicinal cannabis can receive different amounts of the active compound for treatment, up to double dose. Furthermore, a patient may react differently to two flowers from the same strain with an identical THC:CBD ratio.
The efficacy of medical cannabis is not as simple as the THC:CBD ratio. It will take years, if not decades, of dedicated and costly scientific research to decipher the therapeutic potential of the active compounds in cannabis and how their interaction impacts efficacy for specific health conditions. Yet, a promising diagnostic technology to facilitate the personalization of cannabis treatment already exists today.